Background illustration for clinical trials search

Paid Clinical Trials Indianapolis

Discover 901 paid clinical trials in Indianapolis, Indiana. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2
Active & Responsive

Sinonasal Therapies and Histologic Correlations of Patients With Cystic Fibrosis in the Era of Highly Effective Modulator Therapy

for
Cystic Fibrosis (CF), Chronic Rhinosinusitis (CRS)
Location: Indianapolis IN
Sponsor: Indiana University

Sex: All

Age: 18+

Code: NCT06996951

Phase 3, Recruiting
Active & Responsive

The Effects of Cognitive Behavioral Therapy on Insulin Resistance in People With HIV

for
HIV, Depression in Adults, Insulin Resistance,
Location: Indianapolis IN
Sponsor: Indiana University

Sex: All

Age: 18+

Code: NCT07226128

Recruiting
Active & Responsive

A Study to Investigate the Efficacy, Safety and Tolerability of Votoplam in Participants With Huntington's Disease

for
Huntington Disease
Location: Indianapolis IN, Chicago IL, Grand Rapids MI,
Sponsor: Novartis Pharmaceuticals

Sex: All

Age: 21 - 70

Code: NCT07326709

Phase 3, Recruiting
Active & Responsive

HER2 Vaccine for Locally Advanced Breast Cancer

for
Breast Cancer, HER2-positive Breast Cancer
Location: Indianapolis IN
Sponsor: Pravin T.P Kaumaya

Sex: All

Age: 18+

Code: NCT06949410

Phase 1, Recruiting
Active & Responsive

HER-2 B Cell Peptide Vaccine

for
Metastatic Breast Cancer, HER2-positive Breast Cancer,
Location: Indianpolis IN
Sponsor: Pravin T.P Kaumaya

Sex: All

Age: 18+

Code: NCT06414733

Phase 1, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image
Active & Responsive

Measuring if Immunotherapy Plus Chemotherapy is Better Than Chemotherapy Alone for Patients With Aggressive Poorly Differentiated Sarcomas

for
Metastatic Dedifferentiated Liposarcoma,
Location: Indianapolis IN, Danville IL, Greenville OH,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT06422806

Phase 3, Recruiting
Active & Responsive

Efficacy & Safety of Olvi-Vec and Platinum-doublet + Bevacizumab Compared to Physician's Choice of Chemotherapy and Bevacizumab in Platinum-Resistant/Refractory Ovarian Cancer (PRROC) (OnPrime, GOG-3076)

for
Platinum-resistant Ovarian Cancer,
Location: Indianapolis IN, Kettering OH, Columbus OH, Sylvania OH,
Sponsor: Genelux Corporation

Sex: Female

Age: 18+

Code: NCT05281471

Phase 3, Recruiting
Active & Responsive

Comparing Combinations of Drugs to Treat Newly Diagnosed Multiple Myeloma (NDMM) When a Stem Cell Transplant is Not a Medically Suitable Treatment

for
Plasma Cell Myeloma
Location: Indianapolis IN, Carmel IN, Richmond IN, Danville IL,
Sponsor: SWOG Cancer Research Network

Sex: All

Age: 0+

Code: NCT05561387

Phase 3, Recruiting
Active & Responsive

Study of Pembrolizumab, Carboplatin, Paclitaxel, and Radiation for the Treatment of Early-Stage Anal Cancer

for
Anal Cancer
Location: Indianapolis IN, Madison WI, Iowa City IA, Baltimore MD,
Sponsor: Dustin Deming

Sex: All

Age: 18+

Code: NCT06493019

Phase 2, Recruiting
Active & Responsive

ASCVD Management Using CCTA in Prostate Cancer Patients on ADT

for
Prostate Cancer
Location: Indianapolis IN, Carmel IN
Sponsor: Indiana University

Sex: Male

Age: 40+

Code: NCT05879913

Recruiting
Active & Responsive

Pre-Rehabilitation for Female Patients Undergoing Pelvic Radiotherapy

for
Dyspareunia, Pelvic Pain, Sexual Dysfunction,
Location: Indianapolis IN, Avon IN, Carmel IN
Sponsor: Indiana University

Sex: Female

Age: 18+

Code: NCT06059586

Recruiting
Active & Responsive

A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Colorectal Cancer

for
Colorectal Cancer
Location: Indianapolis IN, Grand Rapids MI, St Louis MO,
Sponsor: Verastem, Inc.

Sex: All

Age: 18+

Code: NCT07659795

Phase 2, Recruiting
Active & Responsive

A Substudy of Investigational Agents in Programmed Cell Death-1/Ligand 1 (PD-1/L1) Refractory Locally Advanced or Metastatic Urothelial Carcinoma (mUC) (MK-3475-04A)

for
Urothelial Carcinoma
Location: Indianapolis IN, Chicago IL, Cleveland OH,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT05562830

Phase 1, Phase 2, Recruiting
Active & Responsive

Maintenance Zanzalintinib With Etoposide After HDCT in GCT

for
Germ Cell Tumor
Location: Indianapolis IN
Sponsor: Indiana University

Sex: All

Age: 18+

Code: NCT06937866

Phase 1, Phase 2, Recruiting
Active & Responsive

Lurbinectedin With Osimertinib in Transformed Small Cell Lung Cancer

for
Small Cell Lung Cancer ( SCLC ),
Location: Indianapolis IN
Sponsor: Misty Shields

Sex: All

Age: 18+

Code: NCT07153055

Phase 1, Phase 2, Recruiting
Active & Responsive

Trial of Zanzalintinib (XL092) in Combination With Immunotherapy in Patients Who Progress on Adjuvant Therapy in Clear Cell RCC

for
Advanced Renal Cell Carcinoma, Metastatic Renal Cell Carcinoma,
Location: Indianapolis IN, Columbus OH, St Louis MO, New York NY,
Sponsor: Karie Runcie

Sex: All

Age: 18+

Code: NCT06863311

Phase 2, Recruiting
Active & Responsive

Temporal Interference Methods for Addiction Treatment

for
Nicotine Use Disorder, Substance Use Disorders
Location: Indianapolis IN, Bloomington IN
Sponsor: Indiana University

Sex: All

Age: 21 - 50

Code: NCT07210268

Recruiting
Active & Responsive

A Study of Brenipatide in Adult Participants With Major Depressive Disorder

for
Depressive Disorder, Major
Location: Indianapolis IN, St Louis MO, Troy MI, Sarnia,
Sponsor: Eli Lilly and Company

Sex: All

Age: 18 - 70+

Code: NCT07412756

Phase 3, Recruiting
Active & Responsive

A Study of Brenipatide in Participants With Opioid Use Disorder

for
Opioid Use Disorder
Location: Indianapolis IN, Lexington KY, Chicago IL, Columbus OH,
Sponsor: Eli Lilly and Company

Sex: All

Age: 18 - 70+

Code: NCT07420283

Phase 2, Recruiting
Active & Responsive

rTMS to Target Neural Connectivity and Rumination in Treatment-Resistant Depression

for
Depression, Treatment Resistant
Location: Indianapolis IN
Sponsor: Indiana University

Sex: All

Age: 18 - 70

Code: NCT06511544

Recruiting